The success of Sildenafil initially drove a surge for the drug industry, however recent developments present a uncertain outlook for those considering a stake. Generic alternatives are eating into earnings, and ongoing https://zubairvzbj673159.blogsumer.com/40083454/the-blue-pill-and-the-pharmaceutical-industry-a-risky-bet